References
- Adediran OS, Ohwovoriole AE. Prevalence of the metabolic syndrome among Nigerians with type 2 diabetes mellitus. Poster presentation. 18th International Diabetes Federation Congress on Diabetes Metabolism, August 24–29, Paris, France, 4s30–4s31, 2003.
- Alberti KG, Zimmet P, Shaw J. Metabolic syndrome – a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabetes Med 23, 460–469, 2006.
- Alebiosu OC, Odusan BO. Metabolic syndrome in subjects with type 2 diabetes mellitus. J Natl Med Assoc 96, 817–821, 2004.
- Chaiken RL, Banerji MA, Huey H, Levbovit HE. Do Blacks with NIDDM have an insulin-resistance syndrome? Diabetes 42, 444–449, 1993.
- Elbein SC, Maxwell TM, Schumacher MC. Insulin and glucose levels and prevalence of glucose intolerance in pedigrees with multiple diabetic siblings. Diabetes 40, 1024–1032, 1991.
- Eregie A, Edo A. Diagnosing the metabolic syndrome: A comparative evaluation of three Diagnostic tools. Poster presentation. 19thWorld Diabetes Congress, International Diabetes Federation. December 3–7, 2006. Cape Town, South Africa. Diabetic Medicine 23(Supp l4), 2006.
- Ginner V, Coca A, Sierra A. Increased insulin resistance in salt-sensitive hypertension. J Hum Hypertens 15, 481–485, 2001.
- Gulli G, Ferrannini E, Stern M, Haffner S, DeFronzo RA. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41, 1575–1586, 1992.
- Hotamisligil GS. The role of TNF-alpha and TNF receptors in obesity and insulin resistance. J Intem Med 245, 621–625, 1999.
- Karaman A, Bayram F, Gundogan K, Ozsan M, Karaman H, Kelestimur F. Prevalence of diabetes mellitus and glucose metabolism disorders in the first degree relatives of type 2 diabetic patients. Bratisl Lek Listy 113, 361–367, 2012.
- Ma H, Gong Y, Liu YY, Song J, Tian HM, Chen T, Ran XW. Prevalence of diabetes and prediabetes mellitus in the first-degree relatives of patients with type 2 diabetes in Chengdu. Sichuan Da Xue Xue Bao Yi Xue Ba 42, 264–268, 2011.
- Mohsin A, Zafar J, Imran SM, Zaheer K, Khizar B, Qazi R A. Frequency of the metabolic syndrome in adult type2 diabetics presenting to Pakistan Institute of Medical Sciences. J Pak Med Assoc 57, 235–238, 2007.
- Ogbera AO. Prevalence and gender distribution of the metabolic syndrome. Diabetol Metab Syndr 2, 1, 2010.
- Osuji CU, Nzerem BA, Dioka CE, Onwubuya EI. Metabolic syndrome in newly diagnosed type 2 diabetes mellitus using NCEP-ATP III, the Nnewi experience. Nig J of Clin Prac 15, 475–480, 2012.
- Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2, 131–141, 1979.
- Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37, 1595–1607, 1988.
- Rosolova H. The sympathetic nervous system and insulin resistance. Vnitr Lek 49, 61–65, 2003.
- Shaw JT, Purdie DM, Neil HA, Levy JC, Turner RC. The relative risks of hyperglycaemia, obesity and dyslipidaemia in the relatives of patients with Type II diabetes mellitus. Diabetologia 42, 24–27, 1999.
- Siewert S, Filipuzzi S, Codazzi L, Gonzalez I, Ojeda MS. Impact of metabolic syndrome risk factors in first-degree relatives of type2 diabetic patients. Rev Diabet Stud 4, 117–184, 2007.
- Stewart MW, Humphriss DB, Berrish TS, Barriocanal LA, Trajano LR, Alberti KG, Walker M. Features of syndrome X in first-degree relatives of NIDDM patients. Diabetes Care 18, 1020–1022, 1995.
- The IDF consensus worldwide definition of the metabolic syndrome. 2006. http://www.idf.org/webdata/docs/idf_meta_def_final.pdf.
- The Metabolic Syndrome, WHO criteria. 1999. https://www.staff.ncl.ac.uk/philip.home/who_dmc.htm/who_dmg.pdf#DefinDiag
- Trinder P. Determination of glucose in blood using the glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 6, 24–27, 1969.
- Verges BL. Dyslipidemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis. Diabetes Metab 25, 32–40, 1999.
- Wellborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2, 154–160, 1976.
- WHO Technical Report Series-854. Physical Status: The use and interpretation of Anthropometry. WHO Geneva1995.
- Zimmet P, Albert G, Shaw J. A new IDF worldwide definition of the metabolic syndrome: the rationale and the results. Diabetes Voice 50, 31–33, 2005.